Sayaka Yoshiba

Summary

Affiliation: Showa University
Country: Japan

Publications

  1. ncbi Hypoxia induces resistance to 5-fluorouracil in oral cancer cells via G(1) phase cell cycle arrest
    Sayaka Yoshiba
    Department of Oral and Maxillofacial Surgery, School of Dentistry, Showa University, Kitasenzoku 2 1 1, Ohta ku, Tokyo 145 8515, Japan
    Oral Oncol 45:109-15. 2009
  2. ncbi Effect of combining epidermal growth factor receptor inhibitors and cisplatin on proliferation and apoptosis of oral squamous cell carcinoma cells
    Sayaka Takaoka
    Department of Oral and Maxillofacial Surgery, Showa University School of Dentistry, Ota ku, Tokyo 145 8515, Japan
    Int J Oncol 30:1469-76. 2007
  3. ncbi Epidermal growth factor receptor inhibitors enhance susceptibility to Fas-mediated apoptosis in oral squamous cell carcinoma cells
    Masayasu Iwase
    Department of Oral and Maxillofacial Surgery, Showa University School of Dentistry, 2 1 1, Kitasenzoku, Ota ku, Tokyo 145 8515, Japan
    Oral Oncol 44:361-8. 2008
  4. ncbi Enhanced susceptibility to apoptosis of oral squamous cell carcinoma cells subjected to combined treatment with anticancer drugs and phosphatidylinositol 3-kinase inhibitors
    Masayasu Iwase
    Department of Oral and Maxillofacial Surgery, Showa University School of Dentistry, Ota ku, Tokyo 145 8515, Japan
    Int J Oncol 31:1141-7. 2007
  5. ncbi Antitumor activity of suberoylanilide hydroxamic acid against human oral squamous cell carcinoma cell lines in vitro and in vivo
    Tatsuhito Nagumo
    Department of Oral and Maxillofacial Surgery, Showa University, Kitasenzoku, Ohta ku, Tokyo, Japan
    Oral Oncol 45:766-70. 2009
  6. ncbi Proteasome inhibitor sensitizes oral squamous cell carcinoma cells to TRAIL-mediated apoptosis
    Sayaka Yoshiba
    Department of Oral and Maxillofacial Surgery, Showa University School of Dentistry, 2 1 1 Kitasenzoku, Ota ku, Tokyo 145 8515, Japan
    Oncol Rep 25:645-52. 2011
  7. ncbi Enhanced susceptibility to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in oral squamous cell carcinoma cells treated with phosphatidylinositol 3-kinase inhibitors
    Makiko Uchida
    Department of Oral and Maxillofacial Surgery, Showa University School of Dentistry, Tokyo, Japan
    Int J Oncol 30:1163-71. 2007

Collaborators

Detail Information

Publications7

  1. ncbi Hypoxia induces resistance to 5-fluorouracil in oral cancer cells via G(1) phase cell cycle arrest
    Sayaka Yoshiba
    Department of Oral and Maxillofacial Surgery, School of Dentistry, Showa University, Kitasenzoku 2 1 1, Ohta ku, Tokyo 145 8515, Japan
    Oral Oncol 45:109-15. 2009
    ..From these findings, we concluded that HS OSCC cells acquire 5-FU resistance under hypoxia by G(1)/S transition through an upregulation of cell cycle inhibitors...
  2. ncbi Effect of combining epidermal growth factor receptor inhibitors and cisplatin on proliferation and apoptosis of oral squamous cell carcinoma cells
    Sayaka Takaoka
    Department of Oral and Maxillofacial Surgery, Showa University School of Dentistry, Ota ku, Tokyo 145 8515, Japan
    Int J Oncol 30:1469-76. 2007
    ..These results suggest that EGFR inhibitors may represent a novel strategy for overcoming resistance to cisplatin-mediated apoptosis via the phosphatidylinositol 3-kinase/Akt pathway...
  3. ncbi Epidermal growth factor receptor inhibitors enhance susceptibility to Fas-mediated apoptosis in oral squamous cell carcinoma cells
    Masayasu Iwase
    Department of Oral and Maxillofacial Surgery, Showa University School of Dentistry, 2 1 1, Kitasenzoku, Ota ku, Tokyo 145 8515, Japan
    Oral Oncol 44:361-8. 2008
    ..These results suggest that the EGFR signaling pathway may, in part, regulate Fas-mediated apoptosis in OSCC cells through c-FLIP expression...
  4. ncbi Enhanced susceptibility to apoptosis of oral squamous cell carcinoma cells subjected to combined treatment with anticancer drugs and phosphatidylinositol 3-kinase inhibitors
    Masayasu Iwase
    Department of Oral and Maxillofacial Surgery, Showa University School of Dentistry, Ota ku, Tokyo 145 8515, Japan
    Int J Oncol 31:1141-7. 2007
    ..These findings could potentially lead to new strategies for improving the efficacy of anticancer drugs in OSCC cells...
  5. ncbi Antitumor activity of suberoylanilide hydroxamic acid against human oral squamous cell carcinoma cell lines in vitro and in vivo
    Tatsuhito Nagumo
    Department of Oral and Maxillofacial Surgery, Showa University, Kitasenzoku, Ohta ku, Tokyo, Japan
    Oral Oncol 45:766-70. 2009
    ..Additionally, we observed that the growth of xenograft SAS tumors in nude mice was significantly blocked by the administration of SAHA without major adverse effects...
  6. ncbi Proteasome inhibitor sensitizes oral squamous cell carcinoma cells to TRAIL-mediated apoptosis
    Sayaka Yoshiba
    Department of Oral and Maxillofacial Surgery, Showa University School of Dentistry, 2 1 1 Kitasenzoku, Ota ku, Tokyo 145 8515, Japan
    Oncol Rep 25:645-52. 2011
    ..The proteasome inhibitor MG132 may therefore represent a novel strategy for overcoming resistance to TRAIL-mediated apoptosis in OSCC cells...
  7. ncbi Enhanced susceptibility to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in oral squamous cell carcinoma cells treated with phosphatidylinositol 3-kinase inhibitors
    Makiko Uchida
    Department of Oral and Maxillofacial Surgery, Showa University School of Dentistry, Tokyo, Japan
    Int J Oncol 30:1163-71. 2007
    ..These results suggest that PI 3-K inhibitors may represent a novel strategy for overcoming resistance to TRAIL-mediated apoptosis in OSCC cells...